Boston, MA -- (SBWIRE) -- 12/27/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: 22nd Century Group Inc (OTCBB:XXII), Avita Medical Ltd (ADR) (OTCMKTS:AVMXY), SPROTT RESOURCE CP (OTCMKTS:SCPZF), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT)
22nd Century Group Inc (OTCBB:XXII) decreased -5.19% at the price of $2.01 recently on a traded volume of 369,125.00 shares, in comparison to 344,107.00 shares of average trading volume. So far this year, the stock is up over 168%.
The company has a total market capitalization of $ 369,125.00 and its total outstanding shares are 344,107.00. 22nd Century Group, Inc. (22nd Century Group) is a holding company. The Company’s wholly owned subsidiary, 22nd Century Limited, LLC (22nd Century Ltd), which is a plant biotechnology company.
Has XXII Found The Bottom and Ready To Move Up? Find Out Here
Avita Medical Ltd (ADR) (OTCMKTS:AVMXY) soared 17.44% at the trading price of $2.30 on a traded volume of 46,702.00 shares till now, whereas its average trading volume is 12,797.00 shares. In the last three months, the stock is down -8.71%. The Intra-day range for the stock is $2.05 and $2.38. Avita Medical Limited is an Australia-based medical device company. The Company is engaged in the commercialization of the its regenerative product, and supply of spacers to the adult and adolescent respiratory market.
For How Long AVMXY Gloss will Attract Investors? Find out via this report
SPROTT RESOURCE CP (OTCMKTS:SCPZF) dropped down -1.36% at the $2.17 recently. So far in three months, the stock is down -23.14%. The 52-week range for the stock is $2.09 and $4.77. Its introductory price for the day was $2.21, with the overall traded volume of 146,499.00 shares. Sprott Resource Corp., through its subsidiaries, invests and operates in oil and gas, energy, agriculture and agricultural nutrient projects, precious metals, and other natural resources.
Why Should Investors Buy SCPZF After the Recent Fall? Just Go Here and Find Out
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) after opening its shares at the price of $2.55, dropped -11.53% , its recent trading price was $2.21 for the day. The stock moved on a traded volume of 3.21 million shares, in comparison to 1.31 million shares of average trading volume.
The 52-week range for the stock is $0.53 and $2.59. Its introductory price for the day was $2.55. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications.
Will PVCT Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)